Australia Last Mile Delivery Market to Reach USD 5.41 Bn by 2031 as Quick Commerce and Same-Day Delivery Gain Ground, Says Mordor Intelligence

Australia Last Mile Delivery Market to Reach USD 5.41 Bn by 2031 as Quick Commerce and Same-Day Delivery Gain Ground, Says Mordor Intelligence

Australia Last Mile Delivery Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the Australia Last Mile Delivery Market, offering a comprehensive analysis of

Read Full Article

US Retail Banking Market to Reach USD 1.11 Trillion by 2031 as Digital Banking, Instant Payments and Card Usage Gain Ground, Says Mordor Intelligence

US Retail Banking Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the US Retail Banking Market, offering a comprehensive analysis of trends, growth

Read Full Article

Gabriel Snowboy Turns a Story Written for His Daughter Into a Holiday Fantasy Adventure for Everyone

Before it was a fantasy adventure about an ancient frost giant and a hidden underworld, Galactic Holiday: The Darkside of Christmas Past was a story a father told his daughter

Read Full Article

Chronic Myeloid Leukemia Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 20+ Leading Players Wheeling the Therapeutics Landscape

The Chronic Myeloid Leukemia clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline Chronic Myeloid Leukemia drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US),

Read Full Article

Sickle Cell Disease Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Sickle Cell Disease clinical trial analysis report delivers important insights into ongoing research of 55+ pipeline Sickle Cell Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US),

Read Full Article

Complicated Urinary Tract Infections Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Complicated Urinary Tract Infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline Complicated Urinary Tract Infections drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Read Full Article

Interstitial Lung Disease Clinical Trial Drug Development Pipeline Expands with Contributions from 120+ Key Companies | DelveInsight

The Interstitial Lung Disease Clinical Trials analysis report delivers important insights into ongoing research on 120+ pipeline Interstitial Lung Disease Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US),

Read Full Article

Obesity Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Obesity Clinical Trials analysis report delivers important insights into ongoing research on 80+ pipeline Obesity Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026 –

Read Full Article

Gastric Cancer Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

The Gastric Cancer Clinical Trials analysis report delivers important insights into ongoing research on 200+ pipeline Gastric Cancer Drugs, clinical

Read Full Article

Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Glioblastoma clinical trial analysis report delivers important insights into ongoing research on 200+ pipeline Glioblastoma drugs, clinical strategies, upcoming

Read Full Article

Glioma Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 180+ Leading Players Wheeling the Therapeutics Landscape

The Glioma clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline Glioma drugs, clinical strategies, upcoming

Read Full Article

ANCA Vasculitis Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The ANCA Vasculitis clinical trial analysis report delivers important insights into ongoing research of 12+ pipeline ANCA Vasculitis drugs, clinical

Read Full Article

The PH-ILD Therapeutics Market Size in the 7MM was valued at ~USD 3 billion in 2025 and is projected to expand at a CAGR of 3.9% by 2036

The PH-ILD clinical trial analysis report delivers important insights into ongoing research on multiple pipeline PH-ILD drugs, clinical strategies, upcoming

Read Full Article

COPD Clinical Trial Pipeline Gains Momentum: 65+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Chronic Obstructive Pulmonary Disease clinical trial analysis report delivers important insights into ongoing research of 65+ pipeline Chronic Obstructive

Read Full Article

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 – DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception

The Key Eosinophilic Esophagitis Companies in the market include – Sanofi/Regeneron Pharmaceuticals, Dr. Falk Pharma GmbH, AstraZeneca and Amgen, Ellodi

Read Full Article

Atopic Dermatitis Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Kymab, BiomX, LEO Pharma, GSK, Arjil Pharma, SCM Lifescience, Sun Pharma, Brickell Bio

The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun

Read Full Article

Alzheimer’s Disease Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Alpha Cognition, Biogen, Eisai, Eli Lilly, Otsuka Pharma, Lundbeck, Suven Life Sciences, Roche

The Key Alzheimer’s Disease Companies in the market include – Alpha Cognition, Biogen/Eisai, Eli Lilly, Otsuka Pharma/ Lundbeck, Suven Life

Read Full Article

Multiple Sclerosis Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities by 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Bio, Emerald Health

The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals,

Read Full Article

Non-Hodgkin Lymphoma Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma, Eli Lilly

(Las Vegas, Nevada, United States) – September 10, 2026: As per DelveInsight’s assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 180+ key

Read Full Article

Prostate Cancer Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Bayer, J&J, Astellas Pharma, Pfizer, Janssen R&D, Tesaro, Sanofi, MacroGenics

The Key Prostate Cancer Companies in the market include – Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer,

Read Full Article